Table 2 The relationship between differentiation score and other clinical characteristics
Characteristic | Differentiation | |||
|---|---|---|---|---|
Poor | Moderate | Well | P value | |
Gender | 0.107 | |||
Male | 49 (59.8%) | 27 (32.9%) | 6 (7.3%) | |
Female | 41 (75.9%) | 12 (22.2%) | 1 (1.9%) | |
Age | 0.284 | |||
≤55 years | 53 (71.6%) | 17 (23.0%) | 4 (5.4%) | |
>55 years | 37 (59.7%) | 22 (35.5%) | 3 (4.8%) | |
Chemotherapy regimen | 0.310 | |||
FOLFOX | 24 (60.0%) | 14 (35.0%) | 2 (5.0%) | |
CapeOX | 17 (65.4%) | 9 (34.6%) | 0 (0.0%) | |
TP | 16 (76.2%) | 5 (23.8%) | 0 (0.0%) | |
Others | 33 (67.3%) | 11 (22.4%) | 5 (10.2%) | |